Addressing Exacerbations and OCS Overexposure in Severe Asthma Management

Wednesday, November 1st, 2023 | 11:00 AM - 12:00 PM CT and 1:00 PM - 2:00 PM CT

Asthma costs the healthcare industry about $50 billion each year. When uncontrolled, this disease can affect healthcare resource utilization, work productivity and health-related quality of life.

In this educational webinar, you will learn how to recognize the most common type of severe asthma, the role of biomarker testing and a treatment option that may reduce exacerbations and steroid overexposure.

Learning Points:

Review guidelines to uncover the underlying driver(s) of severe asthma
Discover an approach for targeting eosinophils in the treatment of severe asthma
Learn about the efficacy and safety, including recently published real-world evidence
Assess dosing and administration options to determine the best treatment pathway

Presenters:

Rohit Katial, MD, FAAAAI, FACAAI, FACP

Professor of Medicine, Associate Vice President of Education, Director, Center for Clinical Immunology, Irene J. & Dr. Abraham E. Goldminz, Chair in Immunology and Respiratory Medicine at National Jewish Health & University of Colorado, Denver